Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Accumulation of lysosulfa… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice.

Artikel i vetenskaplig tidskrift
Författare Maria K. Blomqvist
Volkmar Gieselmann
Jan-Eric Månsson
Publicerad i Lipids in health and disease
Volym 10
Nummer/häfte 1
Sidor 28
ISSN 1476-511X
Publiceringsår 2011
Publicerad vid Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi
Sidor 28
Språk en
Länkar dx.doi.org/10.1186/1476-511X-10-28
https://gup.ub.gu.se/file/104864
Ämnesord Animals, Brain, enzymology, metabolism, pathology, Cerebroside-Sulfatase, genetics, metabolism, Chromatography, High Pressure Liquid, Disease Models, Animal, Leukodystrophy, Metachromatic, enzymology, metabolism, Lysosomal Storage Diseases, genetics, metabolism, Male, Mice, Mice, Mutant Strains, Psychosine, analogs & derivatives, metabolism
Ämneskategorier Psykiatri

Sammanfattning

Lysosomal storage diseases are a group of disorders where accumulation of catabolites is manifested in the lysosomes of different cell types. In metachromatic leukodystrophy (Arylsulfatase A [EC.3.1.6.8] deficiency) storage of the glycosphingolipid sulfatide in the brain leads to demyelination, resulting in neuromotor co-ordination deficits and regression. In a mouse model for metachromatic leukodystrophy, the ASA null mutant mouse, the accumulation of sulfatide in correlation to phenotype has been thoroughly investigated. Another lipid species reported to accumulate in patients with metachromatic leukodystrophy is the sulfatide related lipid lysosulfatide. Lysosulfatide was shown to be a cytotoxic compound in cell culture experiments and thus suggested to be involved in the pathology of metachromatic leukodystrophy. In this study, we further investigated the developmental profile of lysosulfatide in the brain of ASA null mutant mice by using high performance liquid chromatography. Lysosulfatide could be detected in the brain of normal mice (ASA +/+) from 1.8 months up to 23.1 months of age. From the age of 8.8 months the lysosulfatide levels remained constant at 1 pmol/mg wet tissue. The developmental change (< 20 months) of brain lysosulfatide showed an accumulation in ASA null mutant mice at ages above one month compared to its normal counterpart (ASA +/+). Thus, the ASA null mutant mouse might be a suitable model to further investigate the role of lysosulfatide in the pathogenesis of metachromatic leukodystrophy.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?